---
title: "Genrix Bio released its first-quarter performance, with a net loss attributable to the parent company of 121 million yuan, narrowing the loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237597484.md"
description: "According to the Zhitong Finance APP, Genrix Bio released its first-quarter report for 2025, with the company's first-quarter operating revenue of 20.1558 million yuan; a net loss attributable to shareholders of the listed company of 121 million yuan, with losses narrowing; a net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, of 145 million yuan, with losses narrowing; basic loss per share of 0.33 yuan/share"
datetime: "2025-04-25T14:56:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237597484.md)
  - [en](https://longbridge.com/en/news/237597484.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237597484.md)
generator: "portal-rs"
---

# Genrix Bio released its first-quarter performance, with a net loss attributable to the parent company of 121 million yuan, narrowing the loss

According to the Zhitong Finance APP, Genrix Bio (688443.SH) released its first-quarter report for 2025, with a revenue of CNY 20.1558 million in the first quarter; a net loss attributable to shareholders of the listed company of CNY 121 million, a narrowed loss; a net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses of CNY 145 million, a narrowed loss; and a basic loss per share of CNY 0.33

### Related Stocks

- [688443.CN](https://longbridge.com/en/quote/688443.CN.md)

## Related News & Research

- [BeOne says FDA approves Tevimbra-based first-line regimen for HER2+ gastroesophageal cancer](https://longbridge.com/en/news/296930925.md)
- [Iman Gadzhi Acquires Stake in €45 Million AI-Powered Cold Email Platform ListKit](https://longbridge.com/en/news/296750846.md)
- [Stocks in Play: GoldHaven Resources Corp](https://longbridge.com/en/news/296873331.md)
- [08:10 ETTruvant Acquires New Jersey-Based Multi-Pak Packaging, a Specialist in Vitamins, Supplements and OTC](https://longbridge.com/en/news/296912238.md)
- [Biovica says DiviTum TKa study in metastatic melanoma is published in Clinical Cancer Research](https://longbridge.com/en/news/296871354.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**